Catalyst
Slingshot members are tracking this event:
Janssen, Johnson & Johnson (JNJ) subsidiary submits FDA approval for Stelara in treating adolescents with moderate to severe plaque psoriasis
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| JNJ | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Dec 15, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Stelara, Plaque Psoriasis, Fda Approval
